fluorine has been researched along with Schizophrenia in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (92.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 1 (4.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Girard, F; Ikehira, H; Obata, T; Okubo, Y; Sassa, T; Suhara, T; Tanada, S | 1 |
KURLAND, AA; NUSSBAUM, K | 1 |
ALBORNOZ-PLATA, A | 1 |
Wagner, HN | 1 |
Buchsbaum, MS; Cappelletti, J; DeLisi, LE; Dowling-Zimmerman, S; Hazlett, E; Holcomb, HH; Johnson, J; King, AC; Morihisa, J; Post, RM | 1 |
Brodie, JD; Christman, DR; Farkas, T; Fowler, JS; Jaeger, J; Wolf, AP | 1 |
Crocq, MA; Durst, P; Macher, JP; Mokrani, MC; Schuff, N | 1 |
Cohen, RM; Gross, M; Semple, WE | 1 |
Boronow, J; Buchsbaum, MS; Carpenter, W; DeLisi, LE; Dowling-Zimmerman, S; Holcomb, HH; Kessler, R; Morihisa, JM; Pickar, D; van Kammen, DP | 1 |
Brodie, JD; Cancro, R; Fowler, J; Gomez-Mont, F; Jaeger, J; Rotrosen, J; Wolf, AP; Wolkin, A | 1 |
Kling, AS; Kuhl, DE; Metter, EJ; Riege, WH | 1 |
Villeneuve, A | 1 |
Tobin, JM | 1 |
Hádlík, J; Misurec, J; Náhunek, K; Rodová, A; Vanýsek, J | 1 |
Náhunek, K; Svestka, J | 1 |
Clark, ML; Colmore, JP; Huber, WK; Kyriakopoulos, AA; Ramsey, HR; Ray, TS | 2 |
Assis, LM; Martins, C; Navarro, MP | 1 |
Hádlik, J; Náhunek, K; Rodová, A; Svestka, J; Vanýsek, J | 1 |
Acebal, EM; Spatz, H | 1 |
Bordeleau, JM; Gauthier, R; Hillel, J; Tétreault, L | 1 |
Moore, DF; Sharpley, P; Small, IF; Small, JG | 1 |
Ezhkov, AA | 1 |
Kristjansen, P | 1 |
Fink, M; Itil, T | 1 |
1 review(s) available for fluorine and Schizophrenia
Article | Year |
---|---|
Positron emission tomography.
Topics: Basal Ganglia; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Glucose; Humans; Oxygen; Oxygen Radioisotopes; Radioisotopes; Schizophrenia; Temporal Lobe; Tomography, Emission-Computed | 1986 |
8 trial(s) available for fluorine and Schizophrenia
Article | Year |
---|---|
19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate.
Topics: Adult; Antipsychotic Agents; Female; Fluorine; Haloperidol; Humans; Injections, Intramuscular; Isotopes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Schizophrenia | 2002 |
[Fluorothyl: pharmacological aspect and clinical use].
Topics: Affective Symptoms; Animals; Bemegride; Bipolar Disorder; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder, Major; Electroconvulsive Therapy; Ethers; Fluorine; Humans; Mice; Pentylenetetrazole; Rats; Schizophrenia; Seizures | 1968 |
Management of the schizophrenic patient in a community psychiatric practice.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents; Butyrophenones; Chronic Disease; Clinical Trials as Topic; Community Mental Health Services; Female; Fluorine; Humans; Male; Middle Aged; Piperidines; Schizophrenia; Trifluperidol | 1968 |
[Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
Topics: Adolescent; Adult; Antidepressive Agents; Butyrophenones; Clinical Trials as Topic; Depressive Disorder, Major; Female; Fluorine; Humans; Light; Male; Middle Aged; Myoclonus; Perphenazine; Piperidines; Placebos; Reflex; Schizophrenia; Trifluperidol | 1970 |
[Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Butyrophenones; Clinical Trials as Topic; Female; Fluorine; Humans; Middle Aged; Perphenazine; Piperidines; Placebos; Schizophrenia | 1970 |
Evaluation of trifluperidol in chronic schizophrenia.
Topics: Adult; Age Factors; Antidepressive Agents; Butyrophenones; Chronic Disease; Clinical Trials as Topic; Female; Fluorine; Hospitalization; Humans; Middle Aged; Piperidines; Placebos; Schizophrenia; Trifluperidol | 1968 |
Evaluation of trifluperidol in chronic schizaphrenia.
Topics: Adult; Antidepressive Agents; Butyrophenones; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Female; Fluorine; Humans; Middle Aged; Piperidines; Placebos; Schizophrenia; Trifluperidol | 1968 |
A double-blind comparative evaluation of flurothyl and ECT.
Topics: Adult; Electroconvulsive Therapy; Ethers; Female; Fluorine; Humans; Interpersonal Relations; Male; Memory; Middle Aged; Orientation; Psychological Tests; Psychotic Disorders; Schizophrenia | 1968 |
16 other study(ies) available for fluorine and Schizophrenia
Article | Year |
---|---|
BIS (2,2,2-TRIFLUORETHYL) ETHER (INDOKLON) MODIFIED WITH SUCCINYLCHOLINE (ANECTINE) AS A CONVULSANT IN PSYCHIATRIC TREATMENT.
Topics: Convulsants; Convulsive Therapy; Electroencephalography; Ether; Ethers; Fluorides; Fluorine; Flurothyl; Humans; Injections, Intravenous; Psychotherapy; Schizophrenia; Scopolamine; Succinylcholine | 1963 |
[DOUBLE ATTEMPTED SUICIDE WITH PHOSPHORUS AND FLUORINE. ENZYMATIC TREATMENT].
Topics: Fluorides; Fluorine; Fluoroacetates; Nialamide; Phosphorus; Phosphorus, Dietary; Poisoning; Schizophrenia; Suicide; Suicide, Attempted; Toxicology | 1964 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1984 |
Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.
Topics: Adult; Brain; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Depressive Disorder; Dominance, Cerebral; Electric Stimulation; Female; Fluorine; Functional Laterality; Glucose; Humans; Male; Pain; Radioisotopes; Schizophrenia; Tomography, Emission-Computed | 1984 |
Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
Topics: Adult; Basal Ganglia; Brain; Cerebral Cortex; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Radioisotopes; Schizophrenia; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.
Topics: Adult; Brain Chemistry; Fluorine; Fluphenazine; Humans; Magnetic Resonance Spectroscopy; Male; Schizophrenia | 1990 |
Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients.
Topics: Adolescent; Adult; Atrophy; Brain; Cerebral Ventricles; Deoxyglucose; Female; Fluorine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioisotopes; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1985 |
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Topics: Adult; Basal Ganglia; Brain; Chronic Disease; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioisotopes; Schizophrenia; Schizophrenic Psychology; Temporal Lobe; Thiothixene; Tomography, Emission-Computed | 1985 |
Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
Topics: Adult; Age Factors; Aged; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Deoxyglucose; Depressive Disorder; Fluorine; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Middle Aged; Radioisotopes; Schizophrenia; Tomography, X-Ray Computed | 1986 |
[Clinical results with trifluoperidol in schizophrenic patients].
Topics: Adolescent; Adult; Antidepressive Agents; Butyrophenones; Fluorine; Humans; Male; Piperidines; Schizophrenia; Trifluperidol | 1966 |
[Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
Topics: Adolescent; Adult; Antidepressive Agents; Butyrophenones; Female; Fluorine; Humans; Male; Middle Aged; Perphenazine; Piperidines; Schizophrenia; Trifluperidol | 1969 |
Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
Topics: Adolescent; Adult; Antidepressive Agents; Butyrophenones; Convulsive Therapy; Electroconvulsive Therapy; Fluorine; Hallucinogens; Humans; Male; Piperidines; Schizophrenia; Trifluperidol | 1967 |
[Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
Topics: Antidepressive Agents; Butyrophenones; Chlorpromazine; Female; Fluorine; Humans; Male; Middle Aged; Piperidines; Schizophrenia; Trifluoperazine | 1967 |
[Treatment of schizophrenic patients with triperidol (trisedil)].
Topics: Antidepressive Agents; Butyrophenones; Catatonia; Female; Fluorine; Humans; Male; Paranoid Disorders; Piperidines; Schizophrenia; Trifluperidol | 1968 |
[Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
Topics: Antidepressive Agents; Butyrophenones; Fluorine; Humans; Mental Disorders; Piperidines; Schizophrenia; Tranquilizing Agents; Trifluperidol | 1968 |
Electroencephalographic effects of trifluperidol.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Butyrophenones; Computers; Dosage Forms; Electroencephalography; Fluorine; Humans; Middle Aged; Piperidines; Schizophrenia; Sleep Stages; Trifluperidol | 1969 |